View Single Post
Old 01-31-2012, 06:00 PM
lurkingforacure lurkingforacure is offline
Senior Member
 
Join Date: Feb 2008
Posts: 1,485
15 yr Member
lurkingforacure lurkingforacure is offline
Senior Member
 
Join Date: Feb 2008
Posts: 1,485
15 yr Member
Default sarcastic post, sorry

Quote:
Originally Posted by indigogo View Post
Here's a link to the story; it was on NPR

http://www.npr.org/blogs/health/2012...he-whole-story

It was part 2 of a two-part story; the link to the first part can be found in the article
I loved the sentence that said depression was"not just about serotonin"! HELLO! Next we will read this earth-shattering shocker: "Parkinson's, it's not just about dopamine". Like most everyone with PD hasn't known this for years.

I also really liked the ending paragraph:

"And researchers say the consistent patient reactions have actually made it more difficult to do good studies of ketamine. The drug's effects are so powerful and distinctive, they say, it's hard to prevent doctors and patients in an experiment from figuring out who got the drug and who didn't."

WHAT? Geez, I thought that's what they've been complaining about all this time, that there was this pesky placebo effect muddying up the results waters and making it difficult to tell whether someone's improvement was placebo or the drug. Sounds like with this ketamine trial, it's very clear, how is that not great?

Thanks for posting this.
lurkingforacure is offline   Reply With QuoteReply With Quote